Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$154M Sell
388,948
-26,388
-6% -$7.51M 0.02% 821
2026
Q1
$72M Sell
415,336
-163,055
-28% -$33.4M 0.01% 1296
2025
Q4
$148M Buy
578,391
+307,002
+113% +$80.5M 0.02% 736
2025
Q3
$70.6M Buy
271,389
+21,291
+9% +$5.6M 0.01% 1313
2025
Q2
$61.1M Sell
250,098
-295,514
-54% -$73.7M 0.01% 1334
2025
Q1
$144M Sell
545,612
-121,965
-18% -$33M 0.03% 684
2024
Q4
$169M Buy
667,577
+157,496
+31% +$42.2M 0.03% 591
2024
Q3
$162M Buy
510,081
+64,634
+15% +$23M 0.04% 499
2024
Q2
$166M Sell
445,447
-29,333
-6% -$9.9M 0.04% 417
2024
Q1
$165M Buy
474,780
+185,311
+64% +$70.2M 0.04% 423
2023
Q4
$133M Sell
289,469
-38,935
-12% -$19.2M 0.04% 463
2023
Q3
$160M Sell
328,404
-53,623
-14% -$25.2M 0.06% 343
2023
Q2
$171M Buy
382,027
+83,976
+28% +$42.3M 0.06% 323
2023
Q1
$145M Buy
298,051
+3,534
+1% +$1.75M 0.05% 343
2022
Q4
$151M Buy
294,517
+146,872
+99% +$77.2M 0.06% 343
2022
Q3
$71.6M Buy
147,645
+2,228
+2% +$1.08M 0.03% 542
2022
Q2
$68.1M Buy
145,417
+3,129
+2% +$1.39M 0.03% 584
2022
Q1
$61.9M Sell
142,288
-21,261
-13% -$8.89M 0.02% 737
2021
Q4
$75.9M Sell
163,549
-49,113
-23% -$21.7M 0.02% 722
2021
Q3
$82.8M Buy
212,662
+6,481
+3% +$2.75M 0.03% 607
2021
Q2
$91.3M Buy
206,181
+8,416
+4% +$3.68M 0.03% 553
2021
Q1
$82.9M Buy
197,765
+28,021
+17% +$11.2M 0.03% 590
2020
Q4
$69.6M Sell
169,744
-92,723
-35% -$38.6M 0.02% 626
2020
Q3
$109M Buy
262,467
+29,824
+13% +$12M 0.04% 376
2020
Q2
$90.2M Buy
232,643
+99,054
+74% +$37.1M 0.04% 402
2020
Q1
$42M Sell
133,589
-13,993
-9% -$4.72M 0.02% 619
2019
Q4
$54.1M Sell
147,582
-39,206
-21% -$12.4M 0.02% 736
2019
Q3
$47.8M Buy
186,788
+23,705
+15% +$6.65M 0.02% 715
2019
Q2
$43.3M Sell
163,083
-36,013
-18% -$9.13M 0.02% 742
2019
Q1
$53M Buy
199,096
+72,243
+57% +$20.8M 0.02% 601
2018
Q4
$36.3M Sell
126,853
-51,250
-29% -$16.2M 0.02% 758
2018
Q3
$60.3M Sell
178,103
-12,734
-7% -$4.14M 0.02% 592
2018
Q2
$56.8M Buy
190,837
+34,682
+22% +$10.2M 0.02% 595
2018
Q1
$42M Sell
156,155
-601,795
-79% -$163M 0.02% 716
2017
Q4
$188M Buy
757,950
+597,654
+373% +$148M 0.08% 259
2017
Q3
$39.1M Sell
160,296
-42,282
-21% -$10.4M 0.02% 723
2017
Q2
$48.7M Sell
202,578
-6,471
-3% -$1.47M 0.03% 571
2017
Q1
$43.1M Sell
209,049
-190,993
-48% -$39.5M 0.02% 607
2016
Q4
$81.6M Sell
400,042
-51,684
-11% -$9.86M 0.05% 385
2016
Q3
$79.9M Buy
451,726
+142,173
+46% +$24.7M 0.05% 378
2016
Q2
$55.7M Buy
309,553
+98,473
+47% +$17.5M 0.04% 463
2016
Q1
$38.6M Sell
211,080
-27,123
-11% -$4.71M 0.03% 561
2015
Q4
$42.5M Buy
238,203
+20,444
+9% +$3.59M 0.03% 561
2015
Q3
$39M Sell
217,759
-89,399
-29% -$16.5M 0.03% 558
2015
Q2
$58.8M Sell
307,158
-241,777
-44% -$44.9M 0.04% 463
2015
Q1
$97.7M Buy
548,935
+133,516
+32% +$21.1M 0.07% 312
2014
Q4
$59.7M Buy
+415,419
New +$56.8M 0.04% 462

Other funds holding HUM

UBS Group's HUM Position: Q2 2026 in Review

UBS Group reduced its Humana (HUM) stake by 6.4% in Q2 2026, selling an estimated $7.51M and leaving 388,948 shares worth $154M. The position accounts for 0.02% of the portfolio, ranked #821.

UBS Group first reported a position in HUM in Q4 2014 and has held it in 47 quarters since. The position peaked at $188M in Q4 2017. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • UBS Group held 388,948 shares of Humana worth $154M as of Q2 2026.
  • UBS Group sold 26,388 Humana shares in Q2 2026, an estimated $7.51M.
  • Humana made up 0.02% of UBS Group's portfolio in Q2 2026, its #821 holding.
  • UBS Group first reported a position in Humana in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Humana position peaked at $188M in Q4 2017.
  • 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.